FDA Roundup: September 17, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-september-17-2024
FDA Issues Draft Guidance on Conducting Multiregional Clinical Trials in Oncology
http://www.fda.gov/news-events/press-announcements/fda-issues-draft-guidance-conducting-multiregional-clinical-trials-oncology
FDA Roundup: September 13, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-september-13-2024
FDA Authorizes First Over-the-Counter Hearing Aid Software
http://www.fda.gov/news-events/press-announcements/fda-authorizes-first-over-counter-hearing-aid-software
FDA Issues Warning Letters to Two Chinese Firms Regarding Data Quality and Integrity Concerns, Violative Lab Practices
http://www.fda.gov/news-events/press-announcements/fda-issues-warning-letters-two-chinese-firms-regarding-data-quality-and-integrity-concerns-violative
FDA Roundup: September 10, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-september-10-2024
FDA Roundup: September 6, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-september-6-2024
Youth E-Cigarette Use Drops to Lowest Level in a Decade
http://www.fda.gov/news-events/press-announcements/youth-e-cigarette-use-drops-lowest-level-decade
La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente
http://www.fda.gov/news-events/press-announcements/la-fda-autoriza-la-vacuna-contra-el-covid-19-de-novavax-actualizada-para-brindar-una-mejor
